Migraine drug is first to tackle debilitating early symptoms

Ubrogepant, currently used primarily to relieve headaches associated with migraine attacks, may also prevent and relieve debilitating migraine pre-symptoms such as fatigue and sensitivity to light, a recent clinical trial suggests. However, only about one in five people appear to benefit from the drug.

Migraine is far more than "just" headache and tortures sufferers very much: Already days to hours before an attack, many complain about sometimes severe symptoms. A preparation approved in the USA can alleviate these complaints. A German expert even speaks of a paradigm shift.

Those who have already experienced migraine attacks know that this is definitely not funny. Now there is legitimate hope for new approaches to treatment

Migraine drug can also help with symptoms that occur before the actual headache begins

A drug to treat migraine, ubrogepant, is also found to reduce common non-headache symptoms that occur in the hours preceding a migraine headache, according to the results of a large phase three clinical trial published in Nature Medicine. The findings suggest that ubrogepant may be the first acute treatment for the symptoms that occur before migraine, which have a considerable impact on daily function.

This Drug Reduces Symptoms Before a Migraine Strikes, Study Shows

A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event.

Migraine drug that treats headache also eases symptoms like dizziness

The drug ubrogepant doesn't just ease the headache of a migraine, but also relieves symptoms like neck stiffness and fatigue if taken early enough